vs

Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and XPEL, Inc. (XPEL). Click either name above to swap in a different company.

XPEL, Inc. is the larger business by last-quarter revenue ($122.3M vs $70.9M, roughly 1.7× Adaptive Biotechnologies Corp). XPEL, Inc. runs the higher net margin — 11.0% vs 4.7%, a 6.2% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs 13.7%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs 16.5%).

ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.

XPEL, Inc. is a global provider of high-performance surface protection solutions primarily for automotive use. Core offerings include paint protection films, window tints, and ceramic coatings, serving vehicle owners, dealerships, and professional installers across North America, Europe, and Asia Pacific.

ADPT vs XPEL — Head-to-Head

Bigger by revenue
XPEL
XPEL
1.7× larger
XPEL
$122.3M
$70.9M
ADPT
Growing faster (revenue YoY)
ADPT
ADPT
+21.4% gap
ADPT
35.1%
13.7%
XPEL
Higher net margin
XPEL
XPEL
6.2% more per $
XPEL
11.0%
4.7%
ADPT
Faster 2-yr revenue CAGR
ADPT
ADPT
Annualised
ADPT
28.1%
16.5%
XPEL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ADPT
ADPT
XPEL
XPEL
Revenue
$70.9M
$122.3M
Net Profit
$3.4M
$13.4M
Gross Margin
73.6%
41.9%
Operating Margin
-27.1%
12.7%
Net Margin
4.7%
11.0%
Revenue YoY
35.1%
13.7%
Net Profit YoY
50.7%
EPS (diluted)
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADPT
ADPT
XPEL
XPEL
Q1 26
$70.9M
Q4 25
$71.7M
$122.3M
Q3 25
$94.0M
$125.4M
Q2 25
$58.9M
$124.7M
Q1 25
$52.4M
$103.8M
Q4 24
$47.5M
$107.5M
Q3 24
$46.4M
$112.9M
Q2 24
$43.2M
$109.9M
Net Profit
ADPT
ADPT
XPEL
XPEL
Q1 26
$3.4M
Q4 25
$-13.6M
$13.4M
Q3 25
$9.5M
$12.9M
Q2 25
$-25.6M
$16.3M
Q1 25
$-29.9M
$8.6M
Q4 24
$-33.7M
$8.9M
Q3 24
$-32.1M
$14.9M
Q2 24
$-46.2M
$15.0M
Gross Margin
ADPT
ADPT
XPEL
XPEL
Q1 26
73.6%
Q4 25
74.6%
41.9%
Q3 25
80.7%
41.8%
Q2 25
69.4%
42.9%
Q1 25
67.6%
42.3%
Q4 24
62.0%
40.6%
Q3 24
64.1%
42.5%
Q2 24
55.3%
43.5%
Operating Margin
ADPT
ADPT
XPEL
XPEL
Q1 26
-27.1%
Q4 25
-17.8%
12.7%
Q3 25
10.9%
13.4%
Q2 25
-42.5%
15.5%
Q1 25
-56.4%
10.7%
Q4 24
-71.3%
11.5%
Q3 24
-70.3%
16.3%
Q2 24
-109.6%
17.5%
Net Margin
ADPT
ADPT
XPEL
XPEL
Q1 26
4.7%
Q4 25
-18.9%
11.0%
Q3 25
10.2%
10.3%
Q2 25
-43.5%
13.1%
Q1 25
-56.9%
8.3%
Q4 24
-71.0%
8.3%
Q3 24
-69.1%
13.2%
Q2 24
-107.0%
13.7%
EPS (diluted)
ADPT
ADPT
XPEL
XPEL
Q1 26
Q4 25
$-0.08
$0.48
Q3 25
$0.06
$0.47
Q2 25
$-0.17
$0.59
Q1 25
$-0.20
$0.31
Q4 24
$-0.22
$0.33
Q3 24
$-0.22
$0.54
Q2 24
$-0.31
$0.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADPT
ADPT
XPEL
XPEL
Cash + ST InvestmentsLiquidity on hand
$77.6M
$50.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$280.3M
Total Assets
$505.9M
$382.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADPT
ADPT
XPEL
XPEL
Q1 26
$77.6M
Q4 25
$70.5M
$50.9M
Q3 25
$55.0M
$64.5M
Q2 25
$43.2M
$49.6M
Q1 25
$50.6M
$23.5M
Q4 24
$47.9M
$22.1M
Q3 24
$38.1M
$21.0M
Q2 24
$59.8M
$15.0M
Stockholders' Equity
ADPT
ADPT
XPEL
XPEL
Q1 26
Q4 25
$218.8M
$280.3M
Q3 25
$204.4M
$269.3M
Q2 25
$179.7M
$255.7M
Q1 25
$190.4M
$235.5M
Q4 24
$202.7M
$225.5M
Q3 24
$223.8M
$218.7M
Q2 24
$241.6M
$201.9M
Total Assets
ADPT
ADPT
XPEL
XPEL
Q1 26
$505.9M
Q4 25
$512.7M
$382.5M
Q3 25
$490.6M
$387.7M
Q2 25
$496.6M
$318.1M
Q1 25
$510.9M
$294.8M
Q4 24
$539.4M
$285.6M
Q3 24
$558.5M
$273.0M
Q2 24
$584.9M
$261.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADPT
ADPT
XPEL
XPEL
Operating Cash FlowLast quarter
$2.7M
Free Cash FlowOCF − Capex
$1.6M
FCF MarginFCF / Revenue
1.3%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
0.20×
TTM Free Cash FlowTrailing 4 quarters
$62.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADPT
ADPT
XPEL
XPEL
Q1 26
Q4 25
$2.1M
$2.7M
Q3 25
$-7.1M
$33.2M
Q2 25
$-12.4M
$27.9M
Q1 25
$-28.5M
$3.2M
Q4 24
$-12.5M
$6.3M
Q3 24
$-27.1M
$19.6M
Q2 24
$-17.3M
$26.9M
Free Cash Flow
ADPT
ADPT
XPEL
XPEL
Q1 26
Q4 25
$1.4M
$1.6M
Q3 25
$-7.5M
$32.2M
Q2 25
$-13.1M
$26.9M
Q1 25
$-29.7M
$2.2M
Q4 24
$-12.6M
$4.7M
Q3 24
$-27.4M
$18.3M
Q2 24
$-19.0M
$25.1M
FCF Margin
ADPT
ADPT
XPEL
XPEL
Q1 26
Q4 25
2.0%
1.3%
Q3 25
-8.0%
25.6%
Q2 25
-22.2%
21.6%
Q1 25
-56.7%
2.1%
Q4 24
-26.5%
4.4%
Q3 24
-59.0%
16.2%
Q2 24
-44.1%
22.8%
Capex Intensity
ADPT
ADPT
XPEL
XPEL
Q1 26
Q4 25
0.9%
0.9%
Q3 25
0.4%
0.8%
Q2 25
1.1%
0.8%
Q1 25
2.4%
1.0%
Q4 24
0.2%
1.5%
Q3 24
0.7%
1.1%
Q2 24
4.0%
1.6%
Cash Conversion
ADPT
ADPT
XPEL
XPEL
Q1 26
Q4 25
0.20×
Q3 25
-0.75×
2.56×
Q2 25
1.71×
Q1 25
0.38×
Q4 24
0.71×
Q3 24
1.31×
Q2 24
1.79×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADPT
ADPT

Segment breakdown not available.

XPEL
XPEL

Products$90.9M74%
Service Revenue Installation Labor$23.8M19%
Service Revenue Cutbank Credits$4.1M3%
Service Revenue Software$2.2M2%

Related Comparisons